SYNAPSE MED
LIVE

Serial Number

97065557

Owner

SYNAPSE MEDICINE

Attorney

Todd A. Denys

Filing Date

Oct 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SYNAPSE MED Trademark

Serial Number: 97065557 • Registration: 7874118

SYNAPSE MED is a trademark filed by SYNAPSE MEDICINE on October 8, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SYNAPSE MEDICINE (3 trademarks)

17 rue Vauban
33000 Bordeaux , FR

Entity Type: 99

Trademark Details

Filing Date

October 8, 2021

Registration Date

July 29, 2025

Published for Opposition

July 16, 2024

Goods & Services

Downloadable computer software using artificial intelligence for medical prescription assistance, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence to avoid medical risks and contraindications and for drug interaction prevention, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence for medical prescriptions analysis, namely, software for word processing and establishing standardized directories; none of the above products are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field

Telemedicine services; Prescription assistance modules in the nature of providing information in the field of medical prescriptions via telemedicine platforms; Providing advice relating to medical services provided via telecommunications technology; providing information in the field of telemedicine; providing information in the field of medical prescription; providing information in the field of medical prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field

Research in the field of artificial intelligence for computer software design for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Research in the field of artificial intelligence for computer software design for prescription analysis; Software design and development for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software design and development for prescription analysis; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories in the fields of medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories for prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field; Software as a service (SAAS) services featuring software modules for providing prescription assistance through telemedicine platforms

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 29, 2025 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 16, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 16, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 16, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 16, 2025 REAP
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 16, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 7, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 7, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 3, 2025 AITU
USE AMENDMENT FILED
Mar 10, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 10, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 10, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 7, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 7, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 7, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 7, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2024 CRFA
ASSIGNED TO LIE
May 6, 2024 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 17, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 17, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 17, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 17, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 17, 2024 COAR
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 14, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 14, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 14, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 14, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 16, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 16, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 16, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 14, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 13, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2021 NWOS
NEW APPLICATION ENTERED
Oct 12, 2021 NWAP